Sodium Chloride 0.9% Injection, USP, 1000 mL bags, 12 bags per carton, Rx only, Fresenius Medical...

FDA Drug Recall #D-0777-2023 — Class II — May 23, 2023

Recall Summary

Recall Number D-0777-2023
Classification Class II — Moderate risk
Date Initiated May 23, 2023
Status Terminated
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm Fresenius Medical Care Holdings, Inc.
Location Waltham, MA
Product Type Drugs
Quantity 53,424 bags

Product Description

Sodium Chloride 0.9% Injection, USP, 1000 mL bags, 12 bags per carton, Rx only, Fresenius Medical Care North America, Waltham, MA 02451, NDC # 49230-300-10

Reason for Recall

Lack of assurance of sterility: The product was potentially exposed to below-recommended storage temperatures, which may cause leaks in the packaging.

Distribution Pattern

Product was distributed to 32 clinics in SC, NC and VA.

Lot / Code Information

Lot # 23AU05030, Exp 01/13/2024; 23AU05035, Exp 01/15/2024

Other Recalls from Fresenius Medical Care Holdings, Inc.

Recall # Classification Product Date
D-0490-2025 Class II 0.9% Sodium Chloride Injection, USP, Flexible P... May 27, 2025
D-0608-2024 Class II DELFLEX PERITONEAL DIALYSIS SOLUTION With LOW M... Jun 18, 2024
D-0218-2024 Class II DELFLEX Peritoneal Dialysis Solution in Biofine... Dec 28, 2023
D-0075-2023 Class II 0.9% Sodium Chloride Injection, USP, Each 100 m... Nov 22, 2022
D-0015-2023 Class II 0.9% Sodium Chloride Injection, USP, Each 100 m... Oct 11, 2022

Frequently Asked Questions

Injectable drugs and eye drops must be completely free of microbial contamination because they bypass the body's natural defenses. A contaminated injectable can introduce bacteria or fungi directly into the bloodstream, potentially causing sepsis, meningitis, or localized infections — all of which can be life-threatening. Contamination of sterile products almost always results in a Class I recall. If you received an injectable drug from a recalled lot, contact your healthcare provider immediately, even if you feel well, as some infections can have delayed onset.

Not necessarily. Many drug recalls are initiated because of quality system failures or test results that suggest a product might not meet specifications — even if no patients have reported harm. The FDA uses a precautionary approach: if there is reason to believe quality standards were not met, a recall is required regardless of whether adverse effects have been reported. Class I recalls typically involve a reasonable probability of harm; Class II recalls may cause temporary health issues; Class III recalls are for products unlikely to cause adverse health consequences but that still violate regulations.

Pharmacies typically receive recall notices directly from drug wholesalers and manufacturers within days of the recall being announced. Your pharmacist can look up whether any product in your prescription history matches a recalled lot number. For current recalls, the FDA publishes updates at FDA.gov/safety/recalls-market-withdrawals-safety-alerts and sends MedWatch email alerts for significant drug safety issues. You can sign up for MedWatch alerts at FDA.gov. Most major pharmacy chains also have their own recall notification systems that automatically alert pharmacists when a recalled product is in their inventory.

What Should You Do?

Stop using this medication if affected by this recall. Contact your pharmacist or prescribing doctor immediately for guidance. Do not flush medications — use a drug take-back program.